These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24008003)

  • 41. Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
    Kurtoglu E; Balta S; Sincer I; Altas Y; Atas H; Yilmaz M; Korkmaz H; Erdem K; Akturk E; Demirkol S; Can C
    Angiology; 2014 Oct; 65(9):788-93. PubMed ID: 24163120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.
    Ozaki MR; de Almeida EA
    Exp Toxicol Pathol; 2013 Mar; 65(3):297-304. PubMed ID: 22024507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
    Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
    J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.
    Glynn RJ; Koenig W; Nordestgaard BG; Shepherd J; Ridker PM
    Ann Intern Med; 2010 Apr; 152(8):488-96, W174. PubMed ID: 20404379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.
    Burmeister JE; Miltersteiner DR; Campos BM
    J Nephrol; 2009; 22(1):83-9. PubMed ID: 19229822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
    Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
    Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. My patient has an elevated hs-CRP. What does this mean? What should I do now?
    Khan M; Raza E; Kamal AK
    J Pak Med Assoc; 2012 Feb; 62(2):182-3. PubMed ID: 22755389
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease.
    Sawara Y; Takei T; Uchida K; Ogawa T; Yoshida T; Tsuchiya K; Nitta K
    Intern Med; 2008; 47(17):1505-10. PubMed ID: 18758125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
    Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
    Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
    Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.
    Bellia A; Rizza S; Lombardo MF; Donadel G; Fabiano R; Andreadi K; Quon MJ; Sbraccia P; Federici M; Tesauro M; Cardillo C; Lauro D
    Atherosclerosis; 2012 Jul; 223(1):197-203. PubMed ID: 22658255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].
    Szapáry L; Fehér G
    Orv Hetil; 2012 Jun; 153(22):857-60. PubMed ID: 22641260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
    Rexhaj E; Bär S; Soria R; Ueki Y; Häner JD; Otsuka T; Kavaliauskaite R; Siontis GC; Stortecky S; Shibutani H; Spirk D; Engstrøm T; Lang I; Morf L; Ambühl M; Windecker S; Losdat S; Koskinas KC; Räber L;
    Atherosclerosis; 2024 May; 392():117504. PubMed ID: 38513436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease].
    Sergienko IV; Semenova AE; Masenko VP; Ezhov MV; Gabrusenko SA; Kukharchuk VV; Belenkov IuN
    Kardiologiia; 2007; 47(8):4-7. PubMed ID: 18260902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
    Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA
    Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.